Q-omics provides the consensus-scored RNA5SP523 profile across patient tissues and cancer cell-line models. Additionally, RNA5SP523 RNA expression shows 46 significant mutation-linked associations, with the highest sampling consensus in BRCA.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for RNA5SP523 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Cross-omics associations

This table shows molecular features associated with RNA5SP523 in patient tissues and cancer cell lines. In patient samples, RNA5SP523 shows the broadest associations at the RNA and protein expression levels, with BRCA recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Mutation	46	BRCA (29)	view →
RNA	38	PRAD (12)	view →